Edgar Filing: PYOTT DAVID E I

Ownership Submission

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0287

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

PYOTT DAVID E I

2. Issuer Name and Ticker or Trading Symbol
ALLERGAN INC [AGN]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

__X__ Director	_____ 10% Owner
__X__ Officer (give title below)	_____ Other (specify below)
Chairman, President and CEO

(Last)

(First)

(Middle)

2525 DUPONT DRIVE

3. Date of Earliest Transaction (Month/Day/Year)
12/20/2011

(Street)

IRVINE, CA 92612

4. If Amendment, Date Original Filed(Month/Day/Year)

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	12/20/2011		M		250,000 ⁽¹⁾	A	$ 32.3937	456,923	I	By Living Trust ⁽⁵⁾
Common Stock	12/20/2011		S		250,000 ⁽¹⁾	D	$ 85.9068 ⁽²⁾	206,923	I	By Living Trust ⁽⁵⁾
Common Stock	12/21/2011		M		250,000 ⁽¹⁾	A	$ 32.3937	456,923	I	By Living Trust ⁽⁵⁾
Common Stock	12/21/2011		S		250,000 ⁽¹⁾	D	$ 86.0512 ⁽³⁾	206,923	I	By Living Trust ⁽⁵⁾
Common Stock	12/22/2011		M		66,754 ⁽¹⁾	A	$ 32.3937	273,677	I	By Living Trust ⁽⁵⁾
Common Stock	12/22/2011		S		66,754 ⁽¹⁾	D	$ 86.3453 ⁽⁴⁾	206,923	I	By Living Trust ⁽⁵⁾
Common Stock								31,252	D
Common Stock								2,167.6579	I	By 401(k) Trust ⁽⁶⁾
Common Stock								2,880.125	I	By Esop Trust ⁽⁷⁾

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code
(Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date
(Month/Day/Year)

7. Title and Amount of Underlying Securities
(Instr. 3 and 4)

8. Price of Derivative Security
(Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)

11. Nature of Indirect Beneficial Ownership
(Instr. 4)

Code

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Employee Stock Option (Right to Buy)

$ 32.3937

12/20/2011

250,000

⁽⁸⁾

04/24/2012

Common Stock

250,000

$ 0

316,754

By Living Trust

Employee Stock Option (Right to Buy)

$ 32.3937

12/21/2011

250,000

⁽⁸⁾

04/24/2012

Common Stock

250,000

$ 0

66,754

By Living Trust

Employee Stock Option (Right to Buy)

$ 32.3937

12/22/2011

66,754

⁽⁸⁾

04/24/2012

Common Stock

66,754

$ 0

By Living Trust

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
PYOTT DAVID E I 2525 DUPONT DRIVE IRVINE, CA 92612	X		Chairman, President and CEO

Signatures

/s/ Matthew J. Maletta, attorney-in-fact for David E.I. Pyott		12/22/2011
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 3, 2011.
(2)	The price reported in this Form 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $85.90 to $85.96, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holders of Allergan, Inc., or the staff of the Securities Exchange Commission, the full information regarding the number of shares sold at each price range sert forth in this footnote.
(3)	The price reported in comlumn 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $85.90 to $86.72, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities Exchange Commission, upon request, the full information regarding the number of shares sold at each price within the range set forth in this footnote.
(4)	The price reported in column 4 is the weighted average price. These shares were sold in multiple transaction at prices ranging from $85.90 to $87.11, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities Exchange Commission, upon request, the full information regarding the number of shares sold at each price within the range set forth in this footnote.
(5)	David and Julianna Pyott Living Trust dated June 14, 1999, in which the reporting person has a pecuniary interest and of which the reporting person and his spouse are each trustees.
(6)	Shares allocated to reporting person's SIP account as of reporting date.
(7)	Shares allocated to the reporting person's ESOP account as of reporting date.
(8)	The option became exercisable in four equal annual installments beginning 4/24/2003.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.